KSC Equity Snapshot
009420 Weekly Equity Report
Hanall Biopharma Co., Ltd.
What the company does
Hanall Biopharma Co., Ltd., a pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally. The company offers prescription drugs and over-the-counter products for the treatment of diarrhea, prostatic hyperplasia, androgenetic alopecia, chronic renal failure, hypoparathyroidism, vitamin D-resistant rickets, osteomalacia, osteoporosis, prostate cancer, toxic liver disease, chronic hepatitis, liver cirrhosis, male pattern baldness, functional dyspepsia, diabetes, bacterial infections, peripheral vascular disorders, hypertension, chronic heart failure, skin diseases, hypoproteinemia, diabetic polyneuritis, ulcers, high blood pressure, arthritis, endocrine disorders, spasms, insomnia, muscle pain, hypoproteinemia, gastroesophageal reflux disease, allergic rhinitis, conjunctivitis, dermatitis, chronic urticaria, cholesterol cholelithiasis, …
What the weekly tape is saying
009420 closed the latest completed week at 51,500 KRW. The 4-week return is 11.1% and the 12-week return is -8.8%. Trend Signal is active, Market Dynamics is -0.09. Setup signature: Risk-first tape with a 34/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 50,985 KRW
- Vs Trend Line
- 1.0%
- Fair Value
- 36,532 KRW
- Vs Fair Value
- 41.0%
- 52W High
- 73,000 KRW
- 52W Low
- 24,000 KRW
- Drawdown
- -29.5%
- Range Position
- 56.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 4 weeks
- 52W Active Weeks
- 36
- 52W Active Breadth
- 69.2%
- Sector Scope
- KR Healthcare
- Sector Rank
- 60 of 63
- Sector Percentile
- 4.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 1 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 1 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.09
- 4W MD Change
- 92.5%
- Relative Strength
- -31.66
- 4W RS Change
- 8.4%
- Expectation
- Positive
- Probability
- 55.21%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.5M
- 13W Average
- 2.3M
- 52W Average
- 2.6M
- Vs 13W
- 0.6x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.1%
- 52W Volatility
- 9.5%
- Upside Weeks
- 31
- Downside Weeks
- 20
- Downside Breadth
- 38.5%
- Avg Gain / Loss
- 7.5% / -7.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 2954.9B
Opportunity signals
- Trend Signal is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 51,500 KRW | -11.1% | 50,985 KRW | 36,532 KRW | -0.09 | -31.66 | 1.5M | On |
| 5 Jun 2026 | 57,900 KRW | -7.4% | 50,725 KRW | 36,342 KRW | -0.19 | -23.95 | 2.3M | On |
| 29 May 2026 | 62,500 KRW | 9.6% | 50,338 KRW | 36,111 KRW | -0.47 | -21.26 | 5.7M | On |
| 22 May 2026 | 57,000 KRW | 23.0% | 49,635 KRW | 35,862 KRW | -0.91 | -22.79 | 3.4M | On |
| 15 May 2026 | 46,350 KRW | 5.2% | 48,827 KRW | 35,636 KRW | -1.15 | -34.58 | 1.8M | Off |
| 8 May 2026 | 44,050 KRW | -7.1% | 48,393 KRW | 35,478 KRW | -1.22 | -38.35 | 1.4M | Off |
| 1 May 2026 | 47,400 KRW | -8.1% | 48,090 KRW | 35,334 KRW | -1.21 | -25.28 | 1.3M | On |
| 24 Apr 2026 | 51,600 KRW | 6.2% | 47,670 KRW | 35,175 KRW | -1.03 | -17.74 | 2.0M | On |
| 17 Apr 2026 | 48,600 KRW | 3.1% | 46,973 KRW | 34,975 KRW | -0.40 | -19.45 | 1.3M | On |
| 10 Apr 2026 | 47,150 KRW | 0.2% | 46,417 KRW | 34,800 KRW | 0.19 | -17.91 | 1.8M | On |
| 3 Apr 2026 | 47,050 KRW | -26.9% | 45,978 KRW | 34,642 KRW | 0.58 | -11.31 | 3.3M | On |
| 27 Mar 2026 | 64,400 KRW | 14.0% | 45,475 KRW | 34,474 KRW | 0.83 | 19.47 | 2.7M | On |
| 20 Mar 2026 | 56,500 KRW | 0.4% | 44,323 KRW | 34,179 KRW | 0.67 | -1.24 | 1.7M | On |
| 13 Mar 2026 | 56,300 KRW | 1.6% | 43,388 KRW | 33,932 KRW | 0.50 | 3.48 | 1.5M | On |